Phase I, Open-Label Study to Evaluate Potential Pharmacokinetic of Orally Administered Oseltamivir in Healthy Obese Thai Adult Subjects.
Phase of Trial: Phase I
Latest Information Update: 26 Jan 2016
At a glance
- Drugs Oseltamivir (Primary)
- Indications Influenza virus infections
- Focus Pharmacokinetics
- 23 Dec 2013 Results published in the Antimicrobial Agents and Chemotherapy.
- 07 Oct 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 21 Sep 2010 Planned end date changed from 1 Jun 2010 to 1 Oct 2010 as reported by ClinicalTrials.gov.